Endothelium-dependent and endothelium-independent vasodilatation of the cutaneous circulation in sickle cell disease

European Journal of Clinical Investigation

Volumn 41, Issue 5, 2011, Pages 546-551

  Mohan, Junette S ^a   Lip, Gregory Y H ^a   Blann, Andrew D ^a   Bareford, David ^b   Marshall, Janice M ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b CITY HOSPITAL   (United Kingdom)

Author keywords

Acetylcholine; Endothelium; Iontophoresis; Laser doppler flowmetry; Sickle cell disease; Skin; Sodium nitroprusside

Indexed keywords

ACETYLCHOLINE; HEMOGLOBIN C; NITROPRUSSIDE SODIUM;

ADULT; ARTICLE; CLINICAL ARTICLE; ENDOTHELIAL DYSFUNCTION; FINGER; FOREARM; HUMAN; IONTOPHORESIS; MICROCIRCULATION; PRIORITY JOURNAL; SICKLE CELL ANEMIA; SKIN BLOOD FLOW; VASCULAR ENDOTHELIUM; VASODILATATION;

ADULT; ANEMIA, SICKLE CELL; CASE-CONTROL STUDIES; ENDOTHELIUM, VASCULAR; FINGERS; FOREARM; HUMANS; LASER-DOPPLER FLOWMETRY; MICROCIRCULATION; SKIN; VASODILATION;

EID: 79953747576     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/j.1365-2362.2010.02444.x     Document Type: Article

References (28)

1. Hebbel RP. Adhesive interactions of sickle erythrocytes with endothelium. J Clin Invest 1997;100:S83-6.
2. Francis RB Jr. Platelets, coagulation, and fibrinolysis in sickle cell disease: their possible role in vascular occlusion. Blood Coagul Fibrinolysis 1991;2:341-53.
3. Stuart MJ, Setty BN. Hemostatic alterations in sickle cell disease: relationships to disease pathophysiology. Pediatr Pathol Mol Med 2001;20:27-46.
4. Ataga KI, Orringer EP. Hypercoagulability in sickle cell disease: a curious paradox. Am J Med 2003;115:721-8.
5. Sowemimo-Coker SO, Meiselman HJ, Francis RB Jr. Increased circulating endothelial cells in sickle cell crisis. Am J Hematol 1989;31:263-5.
6. Solovey A, Yi Lin B, Brown P, Choong S, Wagner E, Hebbel RP. Circulating endothelial cells in sickle cell anaemia. N Engl J Med 1997;337:1584-90.
7. Blann AD, Marwah S, Serjeant G, Bareford D, Wright J. Platelet activation and endothelial cell dysfunction in sickle cell disease is unrelated to reduced antioxidant capacity. Blood Coagul Fibrinolysis 2003;14:255-9.
8. Mohan JS, Lip GY, Wright J, Bareford D, Blann AD. Plasma levels of tissue factor and soluble E-selectin in sickle cell disease: relationship to genotype and to inflammation. Blood Coagul Fibrinolysis 2005;16:209-14.
9. Mohan J, Bareford D, Lip GYH, Blann AD. Platelet activation and angiogenesis in sickle cell disease. Br J Haematol 2003;121(Suppl 1):58.
10. Mohan J, Marshall JM. A comparative study in subjects with homozygous sickle cell disease and in normal subjects of responses evoked in forearm vasculature by mild indirect cooling. Clin Auton Res 1994;4:35-40.
11. Mohan JS, Marshall JM, Reid HL, Serjeant GR. Peripheral vascular response to mild indirect cooling in patients with homozygous sickle cell disease and the frequency of painful crisis. Clin Sci (Lond) 1998;94:111-20.
12. Belhassen L, Pelle G, Sediame S, Bachir D, Carville C, Bucherer C et al. Endothelial dysfunction in patients with sickle cell disease is related to selective impairment of shear stress-mediated vasodilation. Blood 2001;97:1584-9.
13. Serjeant GR. Sickle Cell Disease. Oxford: Oxford University Press, 1992.
14. Hendry RG, Marshall JM. Vasoconstrictor products of cyclo-oxygenase activity limit acetylcholine-induced cutaneous vasodilatation in young men. Clin Sci (Lond) 2004;107:323-30.
15. Morris SJ, Shore AC. Skin blood flow responses to the iontophoresis of acetylcholine and sodium nitroprusside in man: possible mechanisms. J Physiol 1996;496:531-42.
16. Katusic ZS, Shepherd JT. Endothelium-derived vasoactive factors: II. Endothelium-dependent contraction. Hypertension 1991;18(Suppl. III):86-92.
17. 2 in the resting tone and contractile responses to acetylcholine and arachidonic acid in canine cerebral arteries. J Cardiovasc Pharmacol 1987;10:517-22.
18. 2 receptor antagonists inhibit endothelium-dependent contractions. Hypertension 1990;15:699-703.
19. 2 as an endotheliuim-derived contracting factor and its interaction with endothelium-derived nitric oxide. J Hypertens 1991;9:729-36.
20. Abou-Elenin K, Xydakis A, Hamdy O, Economides PA, Horton ES, Veves A. The effect of aspirin and various iontophoresis solution vehicles on skin microvascular reactivity. Microvasc Res 2002;63:91-5.
21. Khan F, Litchfield SJ, McLaren M, Veale DJ, Littleford RC, Belch JJF. Oral L-arginine supplementation and cutaneous vascular responses in patients with primary Raynaud's phenomenon. Arthritis Rheum 1997;40:352-7.
22. Noon JP, Walker BR, Hand MF, Webb DJ. Studies with iontophoretic administration of drugs to human dermal vessels in vivo: cholinergic vasodilatation is mediated by dilator prostanoids rather than nitric oxide. Br J Clin Pharmacol 1998;45:545-50.
23. Marwah SS, Wheelwright D, Blann AD, Rea C, Beresford R, Phillips JD et al. Vitamin E correlates inversely with non-transferrin-bound iron in sickle cell disease. Br J Haematol 2001;114:917-9.
24. Klings ES, Farber HW. Role of free radicals in the pathogenesis of acute chest syndrome in sickle cell disease. Respir Res 2001;2:280-5.
25. Jain SK, Williams DM. Reduced levels of plasma ascorbic acid (vitamin C) in sickle cell disease patients: its possible role in the oxidant damage to sickle cells in vivo. Clin Chim Acta 1985;149:257-61.
26. Natta CL, Chen LC, Chow CK. Selenium and glutathione peroxidase levels in sickle cell anemia. Acta Haematol 1990;83:130-2.
27. Noon JP, Haynes WG, Webb DJ, Shore AC. Local inhibition of nitric oxide generation in man reduces blood flow in finger pulp but not in hand dorsum skin. J Physiol 1996;490:501-8.
28. Taddei S, Virdis A, Mattei P, Ghiadoni L, Fasolo CB, Sudano I et al. Hypertension causes premature aging of endothelial function in humans. Hypertension 1997;29:736-43.